Ovarian Stimulation

AI-TOP Study Artificial Intelligence for Trigger Optimization.

Comparison of Follitropin Delta and Follitropin Alfa in Combination With Menotropin

Pharmacokinetics of FSH and hCG Following Multiple Dose of Gonadotropins-IBSA.

Pharmacokinetics of FSH and hCG After a Single Subcutaneous Injection of Gonadotropins-IBSA

PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study

Optimal Stimulation of Hypo-responders Undergoing in Vitro Fertilization (IVF)

Does Recombinant FSH (rFSH, i.g. Gonal F®) as Compared to Human Menopausal Gonadotrophin (hMG) Affect Telomere Length of Cumulus Cells During Antral Follicle Growth and Impact Blastocyst Status?

Follicular Volume at the Time of Final Oocyte Maturation in Poor Responders, and Its Correlation With Oocyte Maturity

Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation

Letrozole /GnRH Antagonist Protocol in Women Over 40 Years Undergoing ICSI Cycle

The Effect of Dual Trigger (GnRH Agonist + hCG) for Final Maturation in Oocyte Donors With History of a Previous Cycle With Suboptimal Response to GnRH Agonist Only Trigger

The Effect of Dual Trigger for Final Oocyte Maturation on IVF/ICSI Outcomes in Patients With Suboptimal Ovarian Response

Conventional Ovarian Stimulation vs. Single Injection Stimulation of Corifollitropin Alfa in Oocyte Donor

Effect of Controlled Ovarian Stimulation in Quality of Oocyte and Embryo

Efficacy and Safety of Medication Used to Stimulate Ovulation

Lutropin Alfa in Women at Risk of Poor Response

Double Ovarian Stimulation as Accumulation Strategy for Older Infertile Patients With Suboptimal Ovarian Response

Mechanical Stimulation of the Ovary for Infertility Treatment in Patients With Very Low Ovarian Reserve

Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles

Antagonist/Letrozole in Poor Responders